Research
OCRA invests more funds into ovarian cancer research than any other public charity.
Read more about Research Read about groundbreaking OCRA-funded research
OCRA's Mission & Impact
Mission & Impact
Our Mission Statement: Ovarian Cancer Research Alliance is dedicated to curing ovarian cancer while improving treatments by advancing innovative science, promoting preventive measures, and advocating for, educating and supporting anyone affected by gynecologic cancers to ensure the best possible care and outcomes.
Results and Milestones
Numbers tell the story of our impact
- Research and Education Funding
- OCRA’s advocacy efforts have helped secure $3.8 billion in federal research and education funding
- $3.8B
- Invested in Science Innovation
- $140M raised and invested in scientific breakthroughs
- $140M
- Individuals Helped Each Year
- Our programs support more than 140,000 individuals annually
- 140K
For each dollar we spend, 81 cents goes to funding critical research and innovative programs
Advancing Research and Fueling Hope
OCRA has both a laser focus and a panoramic view when it comes to the fight against gynecologic cancers.
Center for Public Policy
OCRA has built a team of passionate, dedicated advocates.
Read more about Center for Public Policy Discover our advocacy impact and get involved
Patient Support
In times of adversity, support becomes a beacon of hope.
Read more about Patient Support Learn about our unique programs
OCRA's History of Impact and Innovation
Ovarian Cancer Research Alliance (OCRA) is the oldest and largest ovarian and gynecologic cancer charity in the world. Since its founding in 1994, OCRA has grown into the leading non-government funder of ovarian and related gynecologic cancer research, investing over $140 million in groundbreaking studies. Through innovative education and advocacy efforts, compassionate support programs, and cross-industry collaboration, OCRA is driving progress and pushing the boundaries of what’s possible to improve outcomes for patients and advance research in its quest for a cure.
Related Topics
The Overview: July 2026
SummeRun Raises $260,000+ for Research, Hope and Progress Nearly one thousand runners, walkers, survivors, families, friends, and supporters showed up at Seattle’s Seward Park on Sunday, July 12th, for the 33rd annual Ovarian Cancer Research Alliance (OCRA) Rivkin Family SummeRun, raising more than $260,000 for research and programs that support the gynecologic cancer community. The … Continued
Navigating Platinum-Resistant Ovarian Cancer: Everyday Health Shares Coping Strategies and OCRA Resources
In an article published by Everyday Health, “Coping With the Emotional Challenges of Platinum-Resistant Ovarian Cancer” (June 10, 2026), Ovarian Cancer Research Alliance (OCRA) community member Amanda Widro shares her experience navigating a platinum-resistant ovarian cancer diagnosis. Ovarian cancer is considered platinum-resistant when it recurs within six months of finishing platinum-based chemotherapy. Widro, who was … Continued
OCRA Rivkin Family SummeRun Brings Together Nearly 1,000 Participants for a Day of Hope and Progress for Ovarian Cancer Research
Nearly 1,000 runners, walkers, survivors, families, friends, and supporters gathered at Seattle’s Seward Park on Sunday, July 12, 2026, for the Ovarian Cancer Research Alliance (OCRA) Rivkin Family SummeRun. This year’s event raised more than $260,000. Now in its 33rd year, the event once again transformed the park into a sea of teal and purple, … Continued